Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma

Abstract

Genomic imprinting is an inherited epigenetic phenomenon that results in parental – origin – specific gene expression in somatic cells. Relaxation or loss of this feature in certain genes has been demonstrated in several pediatric and adult neoplasms, suggesting an association with tumorigenesis. We analysed 64 primary untreated head and neck squamous carcinoma for the loss of imprinting in the IGF2 and H19 genes to determine the implications of this alteration in the development and progression of these tumors. Forty-nine (77%) of the 64 tumors were informative for imprinting analyses of these genes. IGF2 and H19 were imprinted in all normal squamous epithelium examined. Twelve (37.5%) of 32 tumors informative for H19 and 11 (40.7%) of 27 tumors informative for IGF2 manifested loss of imprinting. Ten tumors were informative for both genes, of which four maintained the constitutional imprinting and six showed loss of imprinting at either H19 or IGF2. These data suggest that loss of imprinting at the IGF2 and H19 loci play a role in the oncogenesis of head and neck carcinoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 6
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ah-See KW, Cooke TG, Pickford IR, Souter D and Balmain A. . 1994 Cancer Res. 54: 1617–1621.

  • American Cancer Society, Inc. 1997 Cancer Facts & Figures. Atlanta, GA: American Cancer Society.

  • Barlow DP. . 1997 EMBO J. 60: 6899–6906.

  • Bartolomei MS. . 1994 Nature Genet. 6: 220–221.

  • Baylin BS. . 1997 Science 277: 1948–1949.

  • Cattanach BM and Beechey CV. . 1990 Development (suppl) 63–72.

  • Chao L-Y, Huff V, Tomlinson G, Riccardi VM, Strong LC and Saunders GF. . 1993 Nature Genet. 3: 127–131.

  • Christofori G, Naik P and Hanahan D. . 1994 Nature 369: 414–418.

  • Christofori G and Hanahan D. . 1995 Nature Genet. 10: 196–201.

  • Chung W-Y, Yuan L, Feng L, Hensle T and Tycko B. . 1996 Hum. Mol. Genet. 5: 1101–1108.

  • Crouse H. . 1996 Genetics 45: 1425–1443.

  • Cui H, Hedborg F, He L, Nordenskjöld A, Sandstedt B, Pfeifer-Phisson S and Ohlsson R. . 1997 Cancer Res. 57: 4469–4474.

  • Cui H, Horon IL, Ohisson R, Hamilton SR and Feinberg AP. . 1998 Nat. Med. 4: 1276–1280.

  • Dao DD, Schroeder WT, Chao LY, Kikuchi H, Strong LC, Riccardi VM, Pathak S, Nichols WW, Lewis WH and Saunders GF. . 1987 Am. J. Hum. Genet. 41: 202–217.

  • Dao D, Walsh CP, Yuan L, Gorelov D, Feng L, Hensle T, Nisen P, Yamashiro DJ, Bestor TH and Tycko B. . 1999 Hum. Mol. Genet. 8: 1337–1352.

  • Davies SM. . 1993 Cancer Res. 53: 4781–4783.

  • DeChiara TM, Roberson EJ and Efstratiadis A. . 1991 Cell 64: 849–859.

  • El-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H and Huff V. . 1995a Cancer Res. 55: 2656–2659.

  • El-Naggar AK, Hurr K, Huff V, Luna MA, Goepfert H and Batsakis JG. . 1996 Clin. Cancer Res. 2: 903–907.

  • El-Naggar AK, Lai S, Luna MA, Weber RS, Goepfert H and Batsakis JG. . 1995b Int. J. Cancer 64: 196–201.

  • El-Naggar AK, Lai S, Clayman G, Lee J-KJ, Luna MA, Goepfert H and Batsakis JG. . 1997 Am. J. Pathol. 151: 1767–1774.

  • Ezzell C. . 1994 J. NIH Res. 6: 53–58.

  • Feinberg AP. . 1993 Nature Genet. 4: 110–113.

  • Fukuzawa R, Umezawa A, Ochi K, Urano F, Ikeda H and Hata JI. . 1999 Int. J. Cancer 82: 490–491.

  • Kim HT, Choi BH, Niikawa N, Lee TS and Chang SI. . 1998 Am. J. Med. Genet. 80: 391–395.

  • Greally JM, Starr DJ, Hwamy S, Song L, Jaarola M and Zemel S. . 1998 Hum. Mol. Genetics 7: 91–95.

  • Hao Y, Crenshaw T, Moulton T, Newcomb E and Tycko B. . 1993 Nature 365: 764–767.

  • Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D and Baylin SB. . 1995 Cancer Res. 55: 4525–4530.

  • Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H. . 1996 Cancer Res. 56: 480–482.

  • Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve AE and Niikawa N. . 1994 Nature Genet. 6: 305–309.

  • Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T and Takahashi T. . 1995 Oncogene 10: 1193–1198.

  • Lee MP, Brandenburg S, Landes GM, Adams M, Miller G and Feinberg AP. . 1999 Hum. Mol. Genet. 8: 683–690.

  • Li X, Nong Z, Ekström C, Larsson E, Nordlinder H, Hofmann WJ, Trautwein C, Odenthal M, Dienes HP, Elström TJ and Schirmacher P. . 1997 Cancer Res. 57: 2048–2054.

  • Mannens M, Hoovers JMN, Redeker E, Verjaal M, Feinberg AP and Little P. . 1994 Eur. J. Hum. Genet. 2: 3–23.

  • McCann AH, Miller N, O'Meara A, Pedersen I, Keogh K, Gorey T and Dervan PA. . 1996 Hum. Mol. Genet. 5: 1123–1127.

  • Mitsuya K, Sui H, Meguro M, Kugoh H, Jinno Y, Niikawa N and Oshimura M. . 1997 Hum. Mol. Genet. 6: 2243–2246.

  • Montagna M, Menin C, Chieco-Bianchi L and D'Andrea E. . 1994 J. Cancer. Res. Clin. Oncol. 120: 732–736.

  • Morrison IM, Becroft DM, Taniguchi T, Woods CG and Reeve AE. . 1996 Nature Med. 2: 311–316.

  • Neumann B, Kubicka P and Barlow DP. . 1995 Nature Genet. 9: 12–13.

  • Nonomura N, Nishimura K, Miki T, Kanno N, Kojima Y, Yokoyama M and Okuyama A. . 1997 Cancer Res. 57: 2575–2577.

  • Oda H, Kume H, Shimizu Y, Inoue T and Ishikawa T. . 1998 Int. J. Cancer 75: 343–346.

  • Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H, Shiiba K, Souza RF, Meltzer SJ and Horii A. . 1997 Cancer Res. 57: 1851–1854.

  • Papadimitrakopoulou VA, Oh Y, El-Naggar A, Izzo J, Clayman G and Mao L. . 1998 Clin. Cancer Res. 4: 539–544.

  • Parkin DM, Läärä E and Muir CS. . 1988 Int. J. Cancer 41: 184–197.

  • Pershouse MA, El-Naggar AK, Hurr K, Lin-Yung WKA and Steck PA. . 1997 Oncogene 14: 369–373.

  • Peterson K and Sapienza C. . 1993 Ann. Rev. Genet. 27: 7–31.

  • Rachmilewitz J, Elkin M, Looijenga LHL, Verkerk AJ, Gonik B, Lustig O, Werner D, deGroot N and Hochberg A. . 1996 Oncogene 13: 1687–1692.

  • Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE and Feinberg AP. . 1993 Nature 362: 747–749.

  • Randhawa GS, Cui H, Barletta JA, Strichman LZ, Talpaz M, Kantarjan H, Deisseroth AB, Champlin RC and Feinberg AP. . 1998 Blood 91: 3144–3147.

  • Reed AI, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby, Sewell D, Nawroz H, Bartek J and Sidransky D. . 1996 Cancer Res. 56: 3630–3633.

  • Reeve AE, Sih SA, Raizis AM and Feinberg AP. . 1989 Mol. Cell. Biol. 9: 1799–1803.

  • Reik W, Brown KW, Slatter RE, Sartori P, Elliott M and Maher ER. . 1995a Hum. Mol. Genet. 3: 1297–1301.

  • Reik W, Brown KW, Schneid H, Bouc YL, Bickmore W and Maher ER. . 1995b Hum. Mol. Genet. 4: 2379–2385.

  • Ross JA, Schmidt PT, Perentesis JP and Davies SM. . 1999 Cancer 85: 1389–1394.

  • Sabbioni S, Barbanti-Brodano G, Croce CM and Negrini M. . 1997 Cancer Res. 57: 4493–4497.

  • Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL and Feinberg AP. . 1994 Nature Genet. 7: 433–439.

  • Suzuki H, Ueda R, Takahashi T and Takahashi T. . 1994 Nature Genet. 6: 332–333.

  • Swain JL, Stewart TA and Leder P. . 1987 Cell 50: 719–727.

  • Temple IK, James RS, Crolla JA, Sitch FL, Jacobs PA, Howell WM, Betts P, Baum JD and Shield J. . 1995 Nature Genet. 9: 109–113.

  • Thompson JS, Reese KL, DeBaun MR, Perlman EJ and Feinberg AP. . 1996 Cancer Res. 56: 5723–5727.

  • Uyeno S, Aoki Y, Nata M, Sagisaka K, Kayama T, Yoshimoto T and Ono T. . 1996 Cancer Res. 56: 5356–5359.

  • Van Roozendaal CE, Gillis AJ, Klijn JG, Van Ooijen B, Claassen CJ, Eggermont AM, Henzen-Logmans SC, Oosterhuis JW, Foekens JA and Looijenga LH. . 1998 FEBS Lett. 437: 107–111.

  • Verkerk AJ, Ariel I, Dekker MC, Schneider T, van Gurp RJ, de Groot N, Gillis AJ, Oosterhuis JW, Hochberg AA and Looijenga LHJ. . 1997 Oncogene 14: 95–107.

  • Vrana PB, Guan XJ, Ingram RS and Tilghaman SM. . 1998 Nat. Genet. 20: 362–365.

  • Wada M, Seeger RC, Mizognchi H and Koeffler HP. . 1995 Cancer Res. 55: 3386–3388.

  • Wu M-S, Wang H-P, Lin C-C, Shen J-C, Shum C-T, Lee W-J and Lin J-T. . 1997 Cancer Lett. 120: 9–14.

  • Zhan S, Shapiro DN and Helman LJ. . 1995 Oncogene 11: 2503–2507.

Download references

Acknowledgements

We are grateful to Dr Andrew Feinberg for his constructive suggestions and review of the manuscript and to Sue Martinez for typing the manuscript. This work is supported by the Oral Cancer Center Excellence Grant #1P50DE11906-01.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Naggar, A., Lai, S., Tucker, S. et al. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene 18, 7063–7069 (1999). https://doi.org/10.1038/sj.onc.1203192

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203192

Keywords

This article is cited by

Search

Quick links